Skip to content
Home/Companies/Biotech/Pieris Pharmaceuticals

Pieris Pharmaceuticals

Biotech·Germany·Exited 2015·Held 14yr
Entry
2001
Hold
14yr
Exit
2015

Who owns Pieris Pharmaceuticals?

Pieris Pharmaceuticals was owned by Bayern Kapital through Seedfonds Bayern (1996 vintage) from 2001 to 2015, exited via IPO.

Hand-verified · updated 2026-08-10

Bayern Kapital
Investor
Bayern Kapital
Seedfonds Bayern · 1996 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2015

More from Seedfonds Bayern

Other portfolio companies in the same fund.

Constellr
Constellr
Active
Aerospace & DefenceGermany· 2026
encosa
encosa
Active
EnergyGermany· 2026
Ewigbyte
Ewigbyte
Active
Deep TechGermany· 2026
Exergy3
Active
ClimateTechUnited Kingdom· 2026
NanoStruct
NanoStruct
Active
Deep TechGermany· 2026
Nature Robots
Active
AgTechGermany· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Pieris Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Pieris Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue